scispace - formally typeset
A

Arnon D. Cohen

Researcher at Clalit Health Services

Publications -  412
Citations -  9549

Arnon D. Cohen is an academic researcher from Clalit Health Services. The author has contributed to research in topics: Population & Odds ratio. The author has an hindex of 41, co-authored 374 publications receiving 7913 citations. Previous affiliations of Arnon D. Cohen include University of Milan & University of Connecticut.

Papers
More filters
Journal Article

[association of obesity, smoking and socioeconomic strata with the fibromyalgia syndrome].

TL;DR: It is demonstrated that obesity is significantly associated with a higher proportion of fibromyalgia, which underlines the role that obesity plays in inflammation and chronic pain.
Journal ArticleDOI

The prevalence of systemic sclerosis is increased among patients with alopecia areata: a population-based study.

TL;DR: A significant positive association was revealed between AA and SSc and awareness of SSc may be of importance for physicians treating patients with AA, and screening for SSc in patients with relevant symptoms may be considered.
Journal ArticleDOI

The Association between Sarcoidosis and Ischemic Heart Disease-A Healthcare Analysis of a Large Israeli Population.

TL;DR: In this paper, the Cox proportional hazards method was used to assess for variables that were related to increased risk of all-cause mortality, and a log-rank test was performed for survival analysis.
Journal ArticleDOI

The risk of depression and anxiety in patients with familial mediterranean fever – a cross-sectional study

TL;DR: In this paper, a cross-sectional analysis based on the Clalit Health Services database was conducted to examine whether such an association exists using big data analysis methodology, which revealed that the prevalence of both depression and anxiety was higher in the FMF group as compared to controls.
Journal ArticleDOI

Systemic sclerosis is an independent risk factor for ischemic heart disease, especially in patients carrying certain antiphospholipid antibodies: A large cross-sectional study

TL;DR: Patients with SSc are at higher risk for developing IHD with an additional risk for the latter in those positive for aCL or anti-beta2GPI, and a high degree of suspicion is needed during routine patient follow-up and pre-emptive screening should be considered.